Interpharma CEO Dr René P Buholzer outlines the holistic strategy that needs to be put in place to maintain Switzerland’s leading position in innovation, market access and reimbursement challenges for new medicines, and why an open, globalised Europe is key for security of supply. Read the interview below:
Most read articles
30 november 2023
Press Release: Animal Welfare Report 2023: Advancing the principles of the 3Rs with the digitalization of animal research
read more
17 november 2023
«Sustainable Development Goals»: Bayer and Swiss TPH to develop treatment against soil-transmitted helminths
read more
31 august 2023
Health Panorama 2023: here’s to another 90 years of innovation and quality for the healthcare system
read more
More articles on this topic
31 August 2023
Health Panorama 2023: here’s to another 90 years of innovation and quality for the healthcare system
read more
12 May 2023
3 questions to Thorsten Hein – Member of theInterpharma Board and Country Division Head Pharmaceuticals Bayer Switzerland
read more
5 May 2023
3 questions to Graham Dorey – Member Interpharma Board and General Manager Switzerland, Biogen
read more
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2023
read more
Introducing Interpharma
read more
More about the tasks and overriding aims of Interpharma
read more
Contact us
read more
Latest information and media contacts for media representatives
read more
PDF german
Go to store